About

About Seoul National University R&DB Foundation Discover the Power of Innovation at the Seoul National University Pavilion | BIO International 2025, Boston Join us in Boston at BIO 2025 and experience the forefront of biomedical innovation through the Seoul National University (SNU) Pavilion, where academic excellence meets translational impact. At the SNU R&DB Foundation, we champion world-class research by managing intellectual property, accelerating technology transfer, and advancing commercialization. We foster interdisciplinary collaboration, empower academia-industry partnerships, and nurture entrepreneurial growth among SNU’s researchers and students. At Booth #2879, we are proud of presenting a curated selection of next-generation technologies available for global licensing and collaboration, including: • First-in-class small molecules and antibodies targeting liver cancer and MASH • Novel peptides with superior hair growth efficacy • Broad-spectrum antibiotics with powerful efficacy against multidrug-resistant superbugs, developed through drug repositioning • Short peptides with a new mode of action offering both anti-inflammatory and anti-cancer effects, including IBD • Next-generation mesothelin-targeting antibody engineered to overcome proteolytic degradation; and • More game-changing innovations shaping the next era of biotechnology. Explore the future of Korean biotech through seven innovative SNU spin-off companies, each pushing the boundaries of science and commercialization: AIGENDRUG | AI-driven drug discovery platform(DrugVLAB) | www.aigendrug.com CellBion | Radiopharmaceuticals & radioligand therapy | www.cellbion.co.kr CELLinCELLS | Organoid tissue module manufacturing technology | www.cellincells.com ClichemBIO, Inc. | Albumin-based nano theranostics platform for precision nano-medicine | www.clichembio.com Molecular Innovations Inc. | Multifunctional small molecules (Resveratron) for improving skin health and metabolic diseases NIBEC | Proprietary peptides, regenerative biomaterials, and drug delivery systems | https://nibec.co.kr/en/ Portrai | Spatial Transcriptomics-based Drug Discovery Solutions and AI Pathology Analysis System | www.portrai.io We cordially invite you to visit the SNU Pavilion and explore powerful opportunities for partnership, co-development, and strategic investment. Let’s build the future of biotech—together. Meet us in Boston, and let innovation begin. Seoul National University (SNU) Pavilion | BIO International Convention 2026 Discover Partner-Ready Innovation from One of Asia’s Leading Research Universities Join the Seoul National University (SNU) Pavilion at BIO 2026 and connect with a premier hub of translational research and global partnering. Backed by a strong track record in intellectual property management, technology transfer, and successful commercialization, the SNU R&DB Foundation serves as the gateway to high-impact biomedical innovations from Korea’s top-ranked university. We actively collaborate with global pharmaceutical and biotech partners to advance early-stage assets toward clinical and commercial success. Our portfolio is built on rigorous science, validated targets, and strong IP positions—designed for efficient licensing and co-development. We will be showcasing selected innovations at Booth #5535 ○ Hepatitis B virus-derived polypeptides and their therapeutic applications ○ An antibacterial or antifungal composition for preventing or treating bacterial or fungal infections (featuring VLX600) ○ Anti-AXL (and Anti-MERTK) antibody and composition containing the same ○ Novel isoxazole compounds as TM4SF5-specific inhibitors and their therapeutic applications ○ Fc Variants for Modulating FcRn Function ○ Novel CD89(Fc α receptor) binding antibodies and their therapeutic applications Explore a curated lineup of innovative SNU spin-off companies, each advancing breakthrough science toward real-world impact and global commercialization. ○ AIGENDRUG | AI Drug Discovery Platform(DrugVLAB) ○ CellBion | Radioligand therapeutics and diagnostics for prostate cancer ○ CELLinCELLS | 3D Tissue Reforming Technology Platform technology, TRTP-101, TRTP-20X ○ ClichemBIO, Inc. | Albumin nanoplatform, New Drug Development ○ NIBEC | Medical Device, Pepetide CDMO, Peptide-based therapeutics ○ SJChem Meditech, Inc | Oral Drug for Atopic Dermatitis ○ Qureator, Inc. | Curiochips®, Human Disease Models, QuriCore AI™ Platform Meet our team to explore partnership opportunities aligned with your pipeline strategy. Pre-arranged meetings are highly encouraged for in-depth discussions and confidential data sharing.